Liquid biopsy for detection of H3K27m and BRAF V600E mutations in patients with diffuse brainstem tumors
Liquid biopsy is highly informative for identifying the specific mutation H3F3A K28M and often verifies diffuse brainstem glioma without standard biopsy.
Authors
- L. I. Papusha (ORCID: https://orcid.org/0000-0001-7750-5216)
- Andrey Gavrjushin (ORCID: https://orcid.org/0000-0002-8732-3114)
- Margarita Zaytseva (ORCID: https://orcid.org/0000-0003-2015-5790)
- A N Konovalov (ORCID: https://orcid.org/0000-0002-5048-0298)
- A A Veselkov (ORCID: https://orcid.org/0000-0003-2500-3403)
- А. Е. Druy (ORCID: https://orcid.org/0000-0003-1308-8622)
Institutions
- Burdenko Neurosurgery Institute (RU)
- Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology (RU)
Publication Details
- Journal
- Burdenko s Journal of Neurosurgery
- Published
- 2025-02-05
- DOI
- https://doi.org/10.17116/neiro20258901111
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00